FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006837887> ?p ?o ?g. }

• W2006837887 endingPage "205" @default.
• W2006837887 startingPage "203" @default.
• W2006837887 abstract "The molecular mechanisms that regulate functional activation of IL-1α remain elusive. In this issue of Immunity, Zheng et al., 2013Zheng Y. Humphry M. Maguire J.J. Bennett M.R. Clarke M.C.H. Immunity. 2013; 38 (this issue): 285-295Abstract Full Text Full Text PDF PubMed Scopus (147) Google Scholar describe a molecular system implicating interleukin-1 receptor-2 (IL-1R2) as a principal cytosolic factor that controls functional IL-1α activation during necrosis. The molecular mechanisms that regulate functional activation of IL-1α remain elusive. In this issue of Immunity, Zheng et al., 2013Zheng Y. Humphry M. Maguire J.J. Bennett M.R. Clarke M.C.H. Immunity. 2013; 38 (this issue): 285-295Abstract Full Text Full Text PDF PubMed Scopus (147) Google Scholar describe a molecular system implicating interleukin-1 receptor-2 (IL-1R2) as a principal cytosolic factor that controls functional IL-1α activation during necrosis. Inflammation is a coordinated physiological host response to cell damage, stress, or infection. In the context of “sterile inflammation,” a response to cell damage or stress in the absence of pathogens, inflammation is triggered by host-derived factors, called danger-associated molecular patterns (DAMPs), that are released from damaged cells and signal disturbances of cellular or tissue homeostasis. The principal goal of the inflammatory response to DAMPs is restoration of physiological homeostasis through tissue repair. When cell damage or stress associates with the presence of or are directly induced by pathogens, the inflammatory response can be triggered by pathogen-associated molecular patterns (PAMPs). The goals of the host response to PAMPs are pathogen elimination and establishment of immunity. The interleukin-1 (IL-1) family cytokines IL-1α and IL-1β are among the most potent host proteins that activate inflammatory responses to both DAMPs and PAMPs (Dinarello, 2009Dinarello C.A. Annu. Rev. Immunol. 2009; 27: 519-550Crossref PubMed Scopus (2493) Google Scholar). Upon engagement of the IL-1 receptor type 1 (IL-1R1), IL-1α and IL-1β initiate identical biological responses through a signaling cascade that conveys the message that the cellular homeostasis has been disturbed and that the recruitment of specialized cells to initiate tissue repair and/or pathogen elimination is warranted. Apart from being synthesized as precursor proproteins and engaging the same receptor at the plasma membrane, the similarity between IL-1α and IL-1β is limited. Extensive efforts in trying to understand molecular processes that lead to functional activation of IL-1β have resulted in a cohesive model of initiation of inflammation via caspase-1-dependent proteolytic processing of pro-IL-1β and secretion of its mature form from the cell, where the mature p17 IL-1β form is the only biologically active form of this cytokine (Dinarello, 2009Dinarello C.A. Annu. Rev. Immunol. 2009; 27: 519-550Crossref PubMed Scopus (2493) Google Scholar). The caspase-1-dependent processing of pro-IL-1β is tightly controlled by the inflammasome—a supramolecular complex of cytosolic proteins that sense the presence of noxious toxins or pathogen components, and, when prompted, multimerize and activate caspase-1 (Schroder and Tschopp, 2010Schroder K. Tschopp J. Cell. 2010; 140: 821-832Abstract Full Text Full Text PDF PubMed Scopus (4114) Google Scholar). Caspase-1, however, appears to play no role in proteolytic processing of pro-IL-1α, but rather controls its secretion from the cell via a still poorly defined mechanism (Gross et al., 2012Gross O. Yazdi A.S. Thomas C.J. Masin M. Heinz L.X. Guarda G. Quadroni M. Drexler S.K. Tschopp J. Immunity. 2012; 36: 388-400Abstract Full Text Full Text PDF PubMed Scopus (368) Google Scholar; Kuida et al., 1995Kuida K. Lippke J.A. Ku G. Harding M.W. Livingston D.J. Su M.S.S. Flavell R.A. Science. 1995; 267: 2000-2003Crossref PubMed Scopus (1447) Google Scholar). Importantly, and in contrast to IL-1β, both the pro-IL-1α p33 form and its mature p17 IL-1α forms are the functional biologically active ligands for IL-1R1 (Mosley et al., 1987Mosley B. Urdal D.L. Prickett K.S. Larsen A. Cosman D. Conlon P.J. Gillis S. Dower S.K. J. Biol. Chem. 1987; 262: 2941-2944Abstract Full Text PDF PubMed Google Scholar), implying that inflammation can be initiated by IL-1α in various pathological contexts independently of its proteolytic processing. Although secretion of IL-1β is thought to activate systemic inflammatory responses, IL-1α can function both as a secreted and as a membrane-bound cytokine and, thus, trigger and sustain inflammation locally. To this end, IL-1α has been shown to be the principal inducer of inflammation in response to dying and necrotic cells, where the loss of plasma membrane integrity leads to a passive release of IL-1α-containing cytosolic content to the surrounding milieu and initiation of proinflammatory signaling downstream of IL-1R1 (Chen et al., 2007Chen C.J. Kono H. Golenbock D. Reed G. Akira S. Rock K.L. Nat. Med. 2007; 13: 851-856Crossref PubMed Scopus (681) Google Scholar). Because IL-1α is expressed ubiquitously (Dinarello, 2009Dinarello C.A. Annu. Rev. Immunol. 2009; 27: 519-550Crossref PubMed Scopus (2493) Google Scholar), these observations imply that the necrotic death of any cell type in the body should necessarily induce potent local inflammatory responses irrespective of the cell and tissue type. This, however, may not be beneficial to the host under all physiological or pathophysiological circumstances. Exacerbated cell necrosis-driven inflammation in tissues with limited regenerative capacity (for instance, in kidneys or heart) can lead to organ dysfunction or even death. But what can prevent pro-IL-1α from initiating inflammation in response to cellular necrosis, which is, in many cases, an uncontrolled process of catastrophic cell demise? In this issue of Immunity, Zheng et al., 2013Zheng Y. Humphry M. Maguire J.J. Bennett M.R. Clarke M.C.H. Immunity. 2013; 38 (this issue): 285-295Abstract Full Text Full Text PDF PubMed Scopus (147) Google Scholar have revealed an elaborate and elegant molecular system that controls pro-IL-1α biological activity postnecrosis. They implicate a decoy IL-1R type II (IL-1R2) as a key protein that binds pro-IL-1α in the cytosol and prevents its interaction with IL-1R1 upon release from necrotic cells. Initial observations that Zheng et al., 2013Zheng Y. Humphry M. Maguire J.J. Bennett M.R. Clarke M.C.H. Immunity. 2013; 38 (this issue): 285-295Abstract Full Text Full Text PDF PubMed Scopus (147) Google Scholar made have shown that IL-1R1 signaling in response to necrotic cells is highly cell type dependent. They found that although primary human monocyte-derived macrophages, aortic vascular smooth muscle cells (VSMCs), and immortalized Jurkat and HeLa cells expressed similar amounts of pro-IL-1α, upon triggering necrosis, only cytosolic content from VSMCs and not other cell types was able to initiate IL-1R1-dependent responses. Furthermore, the authors found that in necrotic VSMCs, the pro-IL-1α p33 form was readily proteolytically processed to its mature p17 IL-1α form by calpains (Kobayashi et al., 1990Kobayashi Y. Yamamoto K. Saido T. Kawasaki H. Oppenheim J.J. Matsushima K. Proc. Natl. Acad. Sci. USA. 1990; 87: 5548-5552Crossref PubMed Scopus (233) Google Scholar) and that this processing did not occur upon induction of necrosis in other cell types that they analyzed. The authors posited that a cytosolic factor may exist that associates with pre-IL-1α in “noninflammatory” necrotic cell types that blocks both the pro-IL-1α maturation by calpains and its ability to interact with IL-1R1. Although an association of pro-IL-1α with IL-1R2 in the cytosol has been previously reported (Kawaguchi et al., 2006Kawaguchi Y. Nishimagi E. Tochimoto A. Kawamoto M. Katsumata Y. Soejima M. Kanno T. Kamatani N. Hara M. Proc. Natl. Acad. Sci. USA. 2006; 103: 14501-14506Crossref PubMed Scopus (68) Google Scholar), the role of this interaction in regulating inflammation to necrotic cells was not revealed until now. Furthermore, it still remains controversial whether proteolytic processing of pro-IL-1α is ultimately required for its functional activation or whether both the p33 pro-IL-1α and its mature p17 forms are equally potent at inducing IL-1R1-dependent inflammatory responses. Among the reasons that prevented definitive resolution of this question was a poor solubility of recombinant p33 pro-IL-1α form, which complicated comparative analyses of biological activities of the two IL-1α forms. To address this question, Zheng et al., 2013Zheng Y. Humphry M. Maguire J.J. Bennett M.R. Clarke M.C.H. Immunity. 2013; 38 (this issue): 285-295Abstract Full Text Full Text PDF PubMed Scopus (147) Google Scholar expressed two variants of p33 pre-IL-1α, one as a His-tagged form and the other conjugated with GST. Through extensive sets of analyses, the authors demonstrated that calpain-dependent processing significantly increased biological activity of IL-1α. Furthermore, by using an IL-1 receptor antagonist (IL-1RA) competition approach to evaluate the relative affinity of the p33 and p17 IL-1α forms to IL-1R1, the authors concluded that the mature p17 IL-1α form was more efficient at binding IL-1R1 and was 46.3-fold more physiologically active than its p33 pre-IL-1α form. Although these data are in line with recent findings by Afonina et al., 2011Afonina I.S. Tynan G.A. Logue S.E. Cullen S.P. Bots M. Lüthi A.U. Reeves E.P. McElvaney N.G. Medema J.P. Lavelle E.C. Martin S.J. Mol. Cell. 2011; 44: 265-278Abstract Full Text Full Text PDF PubMed Scopus (208) Google Scholar, who demonstrated that pro-IL-1α proteolysis with Granzyme B, calpain, and elastase significantly enhances its biological activity, the ultimate answer to the question on whether pro-IL-1α is a potent biologically active ligand for IL-1R1 could come from analyzing inflammatory responses to necrotic IL-1α-deficient VSMCs that have been reconstituted to express calpain-cleavable or calpain cleavage-resistant forms of pro-IL-1α. The remarkable finding of Zheng et al., 2013Zheng Y. Humphry M. Maguire J.J. Bennett M.R. Clarke M.C.H. Immunity. 2013; 38 (this issue): 285-295Abstract Full Text Full Text PDF PubMed Scopus (147) Google Scholar is that IL-1R2-mediated inhibition of pro-IL-1α availability to processing by calpain and other proteases, including Granzyme B, elastase, and chymase, can be relieved by caspase-1. Specifically, the authors showed that the addition of caspase-1 to IL-1R2 resulted in the proteolytic processing of the latter into two major products. Importantly, upon cleavage of IL-1R2, it dissociated from pro-IL-1α, which then became available to induce IL-1R1-dependent inflammation either directly or after maturation with calpain or other cellular proteases. The designation of caspase-1 as a point of control for functional IL-1α activation is highly significant. Caspase-1 activation is under the tight control of the inflammasomes that sense both DAMPs and PAMPs in the cytosol (Schroder and Tschopp, 2010Schroder K. Tschopp J. Cell. 2010; 140: 821-832Abstract Full Text Full Text PDF PubMed Scopus (4114) Google Scholar). Currently accepted concepts indicate that the proinflammatory function of inflammasomes is enabled through caspase-1-dependent proteolytic processing of pro-forms of IL-1β and IL-18, which, unlike a constitutively expressed pro-IL-1α, are inducible cytokines. In the context of sterile inflammation, where IL-1β expression may not be induced and only the ubiquitously expressed pro-IL-1α is present, inflammasome activation in response to noxious metabolic or damage-derived stimuli will lead to activation of caspase-1, which will target IL-1R2 for degradation and release pro-IL-1α for functional activation by a second protease, calpain, thus triggering local inflammatory response through IL-1R1 (Figure 1 ). This model linking IL-1R2 and caspase-1 to functional activation of IL-1α may have broad implications. This may be the principal mechanism that underlays the pathology of numerous human diseases where local and chronic IL-1R1- and/or caspase-1-dependent inflammation leads to tissue dysfunction in a sterile environment without evident transcriptional IL-1β activation. Moreover, because ligation of the Toll-like receptors leads to potent transcriptional IL-1β activation and the downstream signaling adaptors for IL-1R1 and Toll-like receptors are the same (Dinarello, 2009Dinarello C.A. Annu. Rev. Immunol. 2009; 27: 519-550Crossref PubMed Scopus (2493) Google Scholar), inflammasome-dependent licensing of functional activation of IL-1α by “sterile” stimuli may lead to pro-IL-1β production that will be followed by its caspase-1-dependent processing and release, thus leading to exacerbation of inflammation. In this context, in response to damage or noxious stimulus assault, the initial proinflammatory IL-1R1 signaling can be mediated by IL-1α, while chronic inflammatory response even without any pathogen presence may then be sustained by both IL-1α and IL-1β. Collectively, these data reveal functional redundancy in mechanisms of inflammasome-dependent activation of IL-1R1-mediated proinflammatory responses. The relevance of these findings to explain the mechanistic underpinning for various pathological conditions associated with sustained inflammation in humans now appears as a manageable challenge. Thus, what can make necrosis “silent” by keeping a lid on IL-1α? Now, the answer is clear—it is IL-1R2. Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile InflammationZheng et al.ImmunityFebruary 7, 2013In BriefNecrosis can induce profound inflammation or be clinically silent. However, the mechanisms underlying such tissue specificity are unknown. Interleukin-1α (IL-1α) is a key danger signal released upon necrosis that exerts effects on both innate and adaptive immunity and is considered to be constitutively active. In contrast, we have shown that necrosis-induced IL-1α activity is tightly controlled in a cell type-specific manner. Most cell types examined expressed a cytosolic IL-1 receptor 2 (IL-1R2) whose binding to pro-IL-1α inhibited its cytokine activity. Full-Text PDF Open Access" @default.
• W2006837887 created "2016-06-24" @default.
• W2006837887 creator A5017956331 @default.
• W2006837887 creator A5053669751 @default.
• W2006837887 date "2013-02-01" @default.
• W2006837887 modified "2023-10-14" @default.
• W2006837887 title "Interleukin-1 Receptor 2 Keeps the Lid on Interleukin-1α" @default.
• W2006837887 cites W1571384054 @default.
• W2006837887 cites W1964977785 @default.
• W2006837887 cites W2038182824 @default.
• W2006837887 cites W2063781137 @default.
• W2006837887 cites W2074213282 @default.
• W2006837887 cites W2074729751 @default.
• W2006837887 cites W2076063079 @default.
• W2006837887 cites W2152759011 @default.
• W2006837887 cites W2165275387 @default.
• W2006837887 cites W4211217520 @default.
• W2006837887 doi "https://doi.org/10.1016/j.immuni.2013.02.001" @default.
• W2006837887 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3637128" @default.
• W2006837887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23438818" @default.
• W2006837887 hasPublicationYear "2013" @default.
• W2006837887 type Work @default.
• W2006837887 sameAs 2006837887 @default.
• W2006837887 citedByCount "13" @default.
• W2006837887 countsByYear W20068378872013 @default.
• W2006837887 countsByYear W20068378872014 @default.
• W2006837887 countsByYear W20068378872015 @default.
• W2006837887 countsByYear W20068378872016 @default.
• W2006837887 countsByYear W20068378872017 @default.
• W2006837887 countsByYear W20068378872020 @default.
• W2006837887 countsByYear W20068378872023 @default.
• W2006837887 crossrefType "journal-article" @default.
• W2006837887 hasAuthorship W2006837887A5017956331 @default.
• W2006837887 hasAuthorship W2006837887A5053669751 @default.
• W2006837887 hasBestOaLocation W20068378871 @default.
• W2006837887 hasConcept C170493617 @default.
• W2006837887 hasConcept C203014093 @default.
• W2006837887 hasConcept C2777371288 @default.
• W2006837887 hasConcept C2777977768 @default.
• W2006837887 hasConcept C2778690821 @default.
• W2006837887 hasConcept C54355233 @default.
• W2006837887 hasConcept C74172505 @default.
• W2006837887 hasConcept C86803240 @default.
• W2006837887 hasConceptScore W2006837887C170493617 @default.
• W2006837887 hasConceptScore W2006837887C203014093 @default.
• W2006837887 hasConceptScore W2006837887C2777371288 @default.
• W2006837887 hasConceptScore W2006837887C2777977768 @default.
• W2006837887 hasConceptScore W2006837887C2778690821 @default.
• W2006837887 hasConceptScore W2006837887C54355233 @default.
• W2006837887 hasConceptScore W2006837887C74172505 @default.
• W2006837887 hasConceptScore W2006837887C86803240 @default.
• W2006837887 hasIssue "2" @default.
• W2006837887 hasLocation W20068378871 @default.
• W2006837887 hasLocation W20068378872 @default.
• W2006837887 hasLocation W20068378873 @default.
• W2006837887 hasLocation W20068378874 @default.
• W2006837887 hasOpenAccess W2006837887 @default.
• W2006837887 hasPrimaryLocation W20068378871 @default.
• W2006837887 hasRelatedWork W1575437053 @default.
• W2006837887 hasRelatedWork W2006299775 @default.
• W2006837887 hasRelatedWork W2008992934 @default.
• W2006837887 hasRelatedWork W2038314923 @default.
• W2006837887 hasRelatedWork W2064480570 @default.
• W2006837887 hasRelatedWork W2065343452 @default.
• W2006837887 hasRelatedWork W2084103937 @default.
• W2006837887 hasRelatedWork W2408302605 @default.
• W2006837887 hasRelatedWork W2410833002 @default.
• W2006837887 hasRelatedWork W26474527 @default.
• W2006837887 hasVolume "38" @default.
• W2006837887 isParatext "false" @default.
• W2006837887 isRetracted "false" @default.
• W2006837887 magId "2006837887" @default.
• W2006837887 workType "article" @default.